We are live on ! Find out more
T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $145B
1-Year Est. Return 22.78%
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+22.78%
3 Year Est. Return
+69.87%
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
-$5.16B
Cap. Flow
-$7.02B
Cap. Flow %
-4.43%
Top 10 Hldgs %
22.66%
Holding
961
New
80
Increased
260
Reduced
443
Closed
63

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.18B
2
HOLX
Hologic
HOLX
+$1.14B
3
CI icon
Cigna
CI
+$1.05B
4
ROP icon
Roper Technologies
ROP
+$918M
5
DTE icon
DTE Energy
DTE
+$834M

Sector Composition

Rank Sector Weight
1 Technology 24.82%
2 Healthcare 20.04%
3 Consumer Discretionary 13.58%
4 Financials 12.54%
5 Industrials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CURB
126
Curbline Properties
CURB
$3.49B
$310M 0.2%
13,342,821
+2,365,894
+22% +$55.2M
TCBI icon
127
Texas Capital Bancshares
TCBI
$4.43B
$306M 0.19%
3,376,880
+43,003
+1% +$3.78M
MASI
128
DELISTED
Masimo
MASI
$303M 0.19%
2,330,158
+203,395
+10% +$29.1M
MDLN
129
Medline Inc
MDLN
$31.5B
$298M 0.19%
+7,106,211
New +$300M
APG icon
130
APi Group
APG
$18.8B
$298M 0.19%
7,800,663
-464,110
-6% -$17.2M
EHC icon
131
Encompass Health
EHC
$12.4B
$289M 0.18%
2,722,887
+581,812
+27% +$67.4M
IMNM icon
132
Immunome
IMNM
$3.15B
$288M 0.18%
13,421,987
+5,003,824
+59% +$87.8M
CPK icon
133
Chesapeake Utilities
CPK
$3.3B
$288M 0.18%
2,304,833
-117,554
-5% -$15.5M
SSB icon
134
SouthState Bank Corp
SSB
$10.7B
$287M 0.18%
3,054,672
-360,171
-11% -$33.4M
SRAD icon
135
Sportradar
SRAD
$3.95B
$287M 0.18%
12,080,674
+1,929,037
+19% +$46.4M
ALGN icon
136
Align Technology
ALGN
$12.3B
$286M 0.18%
1,830,038
-426,341
-19% -$61.1M
WING icon
137
Wingstop
WING
$3.14B
$280M 0.18%
1,173,613
+70,224
+6% +$17.4M
WAL icon
138
Western Alliance Bancorporation
WAL
$9.08B
$279M 0.18%
3,315,616
-453,543
-12% -$36.8M
PWR icon
139
Quanta Services
PWR
$102B
$278M 0.18%
659,190
-165,703
-20% -$72.8M
ESI icon
140
Element Solutions
ESI
$9.51B
$278M 0.18%
11,119,999
+1,298,273
+13% +$33.7M
DHR icon
141
Danaher
DHR
$144B
$273M 0.17%
1,192,827
-5,381,510
-82% -$1.18B
BLD
142
DELISTED
TopBuild
BLD
$269M 0.17%
644,151
-5,692
-0.9% -$2.44M
TOST icon
143
Toast
TOST
$19.9B
$255M 0.16%
7,167,843
-3,520,636
-33% -$127M
EBC icon
144
Eastern Bankshares
EBC
$5.37B
$253M 0.16%
13,728,558
+3,407,066
+33% +$62.4M
RBA icon
145
RB Global
RBA
$15.9B
$252M 0.16%
2,448,236
+2,448,196
+6,120,490% +$249M
BANC icon
146
Banc of California
BANC
$3.13B
$250M 0.16%
12,951,761
-526,453
-4% -$9.43M
ALHC icon
147
Alignment Healthcare
ALHC
$2.83B
$250M 0.16%
12,643,784
+79,268
+0.6% +$1.42M
CAI
148
Caris Life Sciences
CAI
$6.39B
$248M 0.16%
9,205,959
+1,180,200
+15% +$33.2M
EFX icon
149
Equifax
EFX
$21.2B
$248M 0.16%
1,141,415
-615,194
-35% -$135M
MDB icon
150
MongoDB
MDB
$36.7B
$241M 0.15%
574,987
+3,014
+0.5% +$1.1M

Similar funds

T. Rowe Price Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, T. Rowe Price Investment Management held 961 positions worth $158B, down 3.2% from $164B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

T. Rowe Price Investment Management withdrew a net $7.02B in Q4 2025, closing 63 positions and reducing 443 holdings. Its most notable exit was Bright Horizons, an estimated $240M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Investment Management opened a new position in Keurig Dr Pepper worth $728M.

  • T. Rowe Price Investment Management's largest Q4 2025 buy was Keurig Dr Pepper: 25,978,817 shares worth $728M.
  • T. Rowe Price Investment Management added most to Cencora in Q4 2025, an estimated $1.41B increase.
  • T. Rowe Price Investment Management's biggest Q4 2025 reduction was Danaher, cutting an estimated $1.18B.
  • T. Rowe Price Investment Management fully exited Bright Horizons in Q4 2025, selling an estimated $240M.
  • T. Rowe Price Investment Management's ten largest holdings make up 23% of its $158B portfolio in Q4 2025.
  • T. Rowe Price Investment Management opened 80 new positions and closed 63 in Q4 2025.
  • T. Rowe Price Investment Management's portfolio value fell 3.2% quarter-over-quarter to $158B.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.